Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 3.945
-0.055 (-1.38%)
Mar 11, 2026, 3:54 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 203.06 million as of March 10, 2026.
Market Cap
203.06M
Enterprise Value
192.71M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.95
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 203.06M, an increase of 33.59%. That is a compound annual growth rate of 51.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 203.06M | 23.00% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 425.23M |
| Dimerix | 225.15M |
| Orthocell | 217.05M |
| Starpharma Holdings | 161.67M |
| Actinogen Medical | 146.60M |
| Island Pharmaceuticals | 125.28M |
| Recce Pharmaceuticals | 124.35M |
| Botanix Pharmaceuticals | 122.00M |